Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant
Open Access
- 6 July 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Cardiothoracic Surgery
- Vol. 2 (1), 32
- https://doi.org/10.1186/1749-8090-2-32
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2006
- B-type natriuretic peptide measured during transfusion-related acute lung injuryTransfusion, 2006
- Small-Dose Recombinant Activated Factor VII (NovoSeven??) in Cardiac SurgeryAnesthesia & Analgesia, 2006
- High dose factor VIIa improves clot structure and stability in a model of haemophilia BBritish Journal of Haematology, 2005
- Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2005
- Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgeryPediatric Critical Care Medicine, 2005
- Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantationThe Journal of Heart and Lung Transplantation, 2005
- Recombinant Coagulation Factor VIIa in Major Liver ResectionAnesthesiology, 2005
- Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenationThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)Anesthesiology, 2003